Hims & Hers Health Debt to Equity Ratio 2020-2025 | HIMS
Current and historical debt to equity ratio values for Hims & Hers Health (HIMS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Hims & Hers Health debt/equity for the three months ending September 30, 2025 was 1.67.
| Hims & Hers Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $1.65B | $0.58B | 2.84 |
| 2025-06-30 | $1.32B | $0.56B | 2.34 |
| 2025-03-31 | $0.34B | $0.55B | 0.62 |
| 2024-12-31 | $0.23B | $0.48B | 0.48 |
| 2024-09-30 | $0.16B | $0.44B | 0.37 |
| 2024-06-30 | $0.12B | $0.36B | 0.33 |
| 2024-03-31 | $0.10B | $0.34B | 0.30 |
| 2023-12-31 | $0.10B | $0.34B | 0.28 |
| 2023-09-30 | $0.09B | $0.33B | 0.26 |
| 2023-06-30 | $0.07B | $0.32B | 0.22 |
| 2023-03-31 | $0.06B | $0.31B | 0.20 |
| 2022-12-31 | $0.06B | $0.31B | 0.18 |
| 2022-09-30 | $0.07B | $0.31B | 0.23 |
| 2022-06-30 | $0.06B | $0.32B | 0.19 |
| 2022-03-31 | $0.05B | $0.33B | 0.17 |
| 2021-12-31 | $0.09B | $0.34B | 0.26 |
| 2021-09-30 | $0.07B | $0.36B | 0.18 |
| 2021-06-30 | $0.06B | $0.29B | 0.19 |
| 2021-03-31 | $0.05B | $0.29B | 0.18 |
| 2020-12-31 | $0.27B | $-0.15B | -1.81 |
| 2020-09-30 | $0.20B | $0.01B | 40.16 |
| 2020-06-30 | $0.20B | $0.01B | 40.24 |
| 2020-03-31 | $0.20B | $0.01B | 40.26 |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.20B | $0.01B | 39.82 |
| 2019-06-30 | $0.00B | $0.00B | 62.85 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.884B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |